We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > COVID-19 variants

News List

CP-COV03, a niclosamide-based oral antiviral drug, under study as possible cure for COVID-19 variants prnasia
December 08, 2021
CP-COV03 is a broad-spectrum antiviral drug candidate, developed by Hyundai Bioscience to treat COVID-19. Its active pharmaceutical ingredient is niclosamide, an anthelmintic drug...
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID prnewswire
May 25, 2021
Seegene Inc. , a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID.